Sodium-Glucose Cotransporter 2 Inhibitor Improves Complications of Lipodystrophy: A Case Report

Ann Intern Med. 2017 Mar 21;166(6):450-451. doi: 10.7326/L16-0372.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / etiology
  • Fatty Liver / drug therapy
  • Fatty Liver / etiology
  • Glucosides / therapeutic use*
  • Glycated Hemoglobin / analysis
  • Humans
  • Insulin Resistance
  • Lipodystrophy / complications
  • Lipodystrophy / congenital
  • Lipodystrophy / drug therapy*
  • Male
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Thiophenes / therapeutic use*

Substances

  • Glucosides
  • Glycated Hemoglobin A
  • Sodium-Glucose Transporter 2 Inhibitors
  • Thiophenes
  • hemoglobin A1c protein, human
  • ipragliflozin